Weight and habits

In type 2 diabetes, fat tissue doesn’t behave alike everywhere in the body. Fat under the skin stays relatively still. Fat settling between the organs in the belly empties elsewhere entirely. Free fatty acids and inflammation messengers this fat releases spill into the vein carrying blood straight to the liver, reaching the organ concentrated. As the load grows, the liver hears insulin’s voice less. Overnight it doesn’t stop releasing sugar into the blood, so the morning reading runs high.

Fat gathering in the liver doesn’t stay there. Some returns to the blood as fat packages, settles inside the pancreas, and spreads among the insulin-making cells. Surrounded by fat, these cells lose the ability to respond fast the moment food arrives. So two loops form, feeding each other: the liver loop grows the pancreas one, the pancreas loop the liver. The two organs don’t watch each other from afar. Their exchange keeps circling through the blood.

The loops turn the other way too. When an energy deficit keeps up, liver fat starts melting within days; pancreas recovery takes months. Improvement follows the same order: the fasting-side picture eases first, the after-meal response recovers later. Major guidelines write that even a small loss of starting weight touches sugar balance. With a bigger loss, numbers leave the diabetes range without diabetes medication and stay out a while. This is called remission; another article covers in whom and how long it lasts.

The picture has a less-known face: type 2 also shows up in thin-looking people, and a notable share of the newly diagnosed sit in the normal weight range. The personal fat threshold idea comes from here. Every body has a limit for storing fat harmlessly, and it varies a lot person to person. Someone past their limit loads fat onto their organs even looking slim from outside. In an overweight person who never crossed that threshold, sugar balance holds for years. Where that threshold sits shows only once crossed.

Where fat sits isn’t directly visible. Fat settling inside the belly doesn’t show on the scale; that’s why body measurements like waist size get tracked alongside weight. The scale gives the total. The waist measurement hints at where that total spread. A precise picture of fat inside the liver and pancreas comes only from imaging methods.

Age, inheritance, and amount of movement are in the same equation too. Corticosteroids and some antipsychotics count among drug groups known to affect weight and sugar balance. Short sleep also weakens the insulin response, with fat mass never changing. In type 1 diabetes the mechanism starts elsewhere entirely (the immune system) and stays outside these loops. Calling weight the only culprit falls short of explaining what’s going on; the exchange between liver and pancreas keeps turning where the scale doesn’t show it.

First, the energy side. As weight drops, less mass must be carried and resting energy use naturally falls; that part is expected. The unexpected part: the fall goes below the calculated figure. Roughly: for each kilogram lost, daily burn falls twenty or thirty calories and appetite rises about a hundred. A far deeper adaptation, measured as still going even years later, was also reported. That finding comes from a small group in an extreme intervention. Behind the scale sticking at the same number months on, this gap usually stands.

The hormone side pulls the same way. The fullness messenger released from fat tissue drops, the stomach’s hunger messenger rises, and fullness signals starting after a meal weaken. Remeasured a year later, the same people’s picture had not returned to its starting point; reported hunger stayed high too. A body that has lost weight produces a stronger hunger than before the loss. The evening urge to go back to the kitchen, an hour after the meal, is its daily form. It is a measurable thing. Guilt adds nothing to this mechanism; it only makes the work heavier.

With diabetes, there’s one more layer. Some blood-sugar-lowering drug families pull the scale up, others down; a separate article covers which goes which way. The other layer is sugar itself. The need to eat appearing near the low limit is not something willpower can argue with; it is plainly a physiological event. That wave differs from ordinary hunger: it comes suddenly, ignores mealtimes, and pulls back soon after you eat. Its signs are not listed one by one here but under “How can you tell your blood sugar is dropping?” Such a wave arriving twice in a day rewrites that day’s plan on its own.

Keeping weight off is a separate job from losing it. Research treats the maintenance stage on its own and lists behaviors most consistently named with it: regular weighing and recording, meals with a set portion, follow-up continued with a person or group. This stage’s job is not reaching a target but keeping a routine standing. Staying in last year’s belt hole asks a different kind of work than the effort of losing it. Regained weight is not proof of weak character. The visible face of an expected tendency.

The evidence is messy. For cinnamon, the reviews disagree. An older systematic review pooling about ten studies found no meaningful difference in sugar measures; a newer one pooling more studies reported a small improvement. For chromium, results swung study to study. Berberine and fenugreek have reviews reporting an effect, but limited to few participants and a few weeks. The problem lands in the same spot every time: small groups, short stretches, products unlike each other.

One reason is this. A plant name is not a standard. A trial extract comes from a particular plant part by a particular method; the grocery-shelf powder from another process. Harvest time, drying and grinding shift the contents too. So a positive trial result doesn’t transfer to another box with the same name. Expecting the same result from the name misleads here.

• Interaction: some herbs taken with a sugar-lowering medication enlarge the combined effect; another article covers how medications affect one another in detail. A drop announces itself with sweating, shaking, a pounding heart, sudden hunger and scattered attention. If this picture grew more frequent after a new product came in, that product may be the reason.
• Oversight: in most places supplements aren’t regulated like drugs; effect and safety need no proof before the shelf, and content and purity vary by batch. A review collecting herbal products sold as sugar-lowering found, in most boxes, a drug ingredient not on the label. The most frequent came from the sulfonylurea group, alongside an older diabetes drug pulled from the market over safety. Harm showed up in two-thirds of those using these products, most commonly a drop in blood sugar.
• Delay: a product thought to work can replace the actual treatment. With no measurement in that stretch, rising values go unrecorded; the situation surfaces only at the next lab test.

Replacing a vitamin or mineral shown to be low is another matter entirely. The best-known example is metformin: long-term use is linked with falling B12 levels, and guidelines bring up checking that level periodically in this group. Closing a known gap is not the same job as picking a product off the shelf hoping to lower sugar.

Evidence and oversight fall short in the same direction here. A drug must show proof; an herbal product with the same claim need not. The sentence on the box comes from a marketing decision, not a study. That sentence is the only measure the person holding the box sees.

A long fast isn’t a single situation. Fasting for faith, planned intermittent fasting schedules, and hungry hours waited out before a procedure start for different reasons. Whatever the reason, the body’s door-opening order stays the same: first the liver’s store, then new glucose production. The piece on skipping meals details that order.

The split starts here. If insulin action is enough, the switch is orderly; if not, fat breakdown goes unbraked and ketones build up. The ketones piece explains how they form and when they come up. If the buildup continues, the outward picture changes too: nausea, vomiting, belly pain, deeper, faster breathing, clear weakness. This picture has a name: ketoacidosis.

Risk isn’t spread evenly. A sugar drop announces itself with sweating, trembling hands, pounding heart, sudden hunger and scattered attention. The warning isn’t always the same strength; with repeated drops and in sleep the signals weaken, and fogginess itself is noticed first. The groups carrying more load are clear:

• People on insulin or an insulin-releasing drug; the drug keeps working, but no carbohydrate arrives.
• People who’ve had a severe drop before, or no longer feel the warning.
• People on an SGLT-2 inhibitor; in a long fast ketones can build even without a rising reading. A separate piece covers this form.
• People with past ketoacidosis, and those with long-standing high blood sugar.
• People with advanced kidney disease, and those pregnant or breastfeeding.

The fluid axis runs separately. In a fast where only food stops, this axis stays out; where drink stops too, the loss builds unnoticed. Blood thickens, urine drops, on a hot day the picture develops much faster. The last hours of a long fast land where fluid and energy both bottom out; both axes strain at once.

The shared frame fits one sentence: risk assessment first, then plan. For a planned fast, assessment comes weeks ahead, weighing current medications, past events and accompanying illnesses together. The outcome isn’t a single yes or no. Some count as low risk, some as high; between them sits one more step, where safety stays unclear. Before a procedure the fast is short; the procedure team sets the plan and the medication schedule is reviewed again. Which arrangement suits whom is decided by the care team that knows the person’s file.